Literature DB >> 17822676

Efficient generation of antigen-specific cellular immunity by vaccination with poly(gamma-glutamic acid) nanoparticles entrapping endoplasmic reticulum-targeted peptides.

Keisuke Matsuo1, Tomoaki Yoshikawa, Atsushi Oda, Takami Akagi, Mitsuru Akashi, Yohei Mukai, Yasuo Yoshioka, Naoki Okada, Shinsaku Nakagawa.   

Abstract

Because antigen-specific cytotoxic T-lymphocytes (CTLs) are major effector cells in tumor immunity, more efficient delivery of tumor-associated antigens to the major histocompatibility complex class I-presentation pathway in antigen-presenting cells (APCs) will substantially contribute to establish more effective cancer immunotherapy. Herein, we demonstrated that a combinational approach based on the antigen-delivery system using poly(gamma-glutamic acid) nanoparticles (gamma-PGA NPs) and an endoplasmic reticulum (ER)-transport system containing an ER-insertion signal sequence (Eriss) significantly enhanced the ability of a peptide vaccine to induce cellular immune responses, including CTL activity. Immunization with gamma-PGA NPs entrapping Eriss-conjugated antigenic peptides markedly amplified and activated CTLs and interferon-gamma-secreting cells specific for the antigen, whereas no cellular immune responses were detected following vaccination with only one of the systems alone. Our data provide evidence that efficient delivery of antigenic peptides into APCs, as well as active ER-translocation of antigenic peptides in APCs should be considered in the development of peptide-based cancer immunotherapy.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17822676     DOI: 10.1016/j.bbrc.2007.08.112

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  6 in total

1.  Quantitative aspects of intracellularly-targeted drug delivery.

Authors:  David Stepensky
Journal:  Pharm Res       Date:  2010-09-02       Impact factor: 4.200

2.  Mitochondrial Targeting Probes, Drug Conjugates, and Gene Therapeutics.

Authors:  Carmine Pasquale Cerrato; Tove Kivijärvi; Ülo Langel
Journal:  Methods Mol Biol       Date:  2022

3.  A nonadjuvanted polypeptide nanoparticle vaccine confers long-lasting protection against rodent malaria.

Authors:  Stephen A Kaba; Clara Brando; Qin Guo; Christian Mittelholzer; Senthilkumar Raman; David Tropel; Ueli Aebi; Peter Burkhard; David E Lanar
Journal:  J Immunol       Date:  2009-11-13       Impact factor: 5.422

Review 4.  Nanoparticle delivery systems in cancer vaccines.

Authors:  Yogita Krishnamachari; Sean M Geary; Caitlin D Lemke; Aliasger K Salem
Journal:  Pharm Res       Date:  2010-08-19       Impact factor: 4.580

5.  Effective transcutaneous immunization by antigen-loaded flexible liposome in vivo.

Authors:  Ni Li; Li-Hua Peng; Xi Chen; Shinsaku Nakagawa; Jian-Qing Gao
Journal:  Int J Nanomedicine       Date:  2011-12-08

Review 6.  Peptide and protein nanoparticle conjugates: versatile platforms for biomedical applications.

Authors:  Christopher D Spicer; Coline Jumeaux; Bakul Gupta; Molly M Stevens
Journal:  Chem Soc Rev       Date:  2018-05-21       Impact factor: 54.564

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.